These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31710943)

  • 1. Stereotactic MR-guided adaptive radiation therapy for peripheral lung tumors.
    Finazzi T; Palacios MA; Haasbeek CJA; Admiraal MA; Spoelstra FOB; Bruynzeel AME; Slotman BJ; Lagerwaard FJ; Senan S
    Radiother Oncol; 2020 Mar; 144():46-52. PubMed ID: 31710943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors.
    Finazzi T; Palacios MA; Spoelstra FOB; Haasbeek CJA; Bruynzeel AME; Slotman BJ; Lagerwaard FJ; Senan S
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):933-941. PubMed ID: 30928360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Daily Plan Adaptation in MR-Guided Stereotactic Ablative Radiation Therapy for Adrenal Metastases.
    Palacios MA; Bohoudi O; Bruynzeel AME; van Sörsen de Koste JR; Cobussen P; Slotman BJ; Lagerwaard FJ; Senan S
    Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):426-433. PubMed ID: 29902559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative planning study for lung SABR between tri-Co-60 magnetic resonance image guided radiation therapy system and volumetric modulated arc therapy.
    Park JM; Park SY; Kim HJ; Wu HG; Carlson J; Kim JI
    Radiother Oncol; 2016 Aug; 120(2):279-85. PubMed ID: 27401404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes of Stereotactic MR-Guided Adaptive Radiation Therapy for High-Risk Lung Tumors.
    Finazzi T; Haasbeek CJA; Spoelstra FOB; Palacios MA; Admiraal MA; Bruynzeel AME; Slotman BJ; Lagerwaard FJ; Senan S
    Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):270-278. PubMed ID: 32105742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen.
    Henke L; Kashani R; Robinson C; Curcuru A; DeWees T; Bradley J; Green O; Michalski J; Mutic S; Parikh P; Olsen J
    Radiother Oncol; 2018 Mar; 126(3):519-526. PubMed ID: 29277446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
    Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
    Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT-guided versus MR-guided radiotherapy: Impact on gastrointestinal sparing in adrenal stereotactic body radiotherapy.
    Rodriguez LL; Kotecha R; Tom MC; Chuong MD; Contreras JA; Romaguera T; Alvarez D; McCulloch J; Herrera R; Hernandez RJ; Mercado J; Mehta MP; Gutierrez AN; Mittauer KE
    Radiother Oncol; 2022 Jan; 166():101-109. PubMed ID: 34843842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
    Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
    Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of magnetic resonance-guided single-fraction stereotactic lung radiotherapy.
    Finazzi T; van Sörnsen de Koste JR; Palacios MA; Spoelstra FOB; Slotman BJ; Haasbeek CJA; Senan S
    Phys Imaging Radiat Oncol; 2020 Apr; 14():17-23. PubMed ID: 33458309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic ablative radiation therapy for subcentimeter lung tumors: clinical, dosimetric, and image guidance considerations.
    Louie AV; Senan S; Dahele M; Slotman BJ; Verbakel WF
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):843-9. PubMed ID: 25585783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico Trial of MR-Guided Midtreatment Adaptive Planning for Hypofractionated Stereotactic Radiation Therapy in Centrally Located Thoracic Tumors.
    Henke LE; Kashani R; Hilliard J; DeWees TA; Curcuru A; Przybysz D; Green O; Robinson CG; Bradley JD
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):987-995. PubMed ID: 29953910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of treatment plans between IMRT with MR-linac and VMAT for lung SABR.
    Park JM; Wu HG; Kim HJ; Choi CH; Kim JI
    Radiat Oncol; 2019 Jun; 14(1):105. PubMed ID: 31196120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MLC tracking for lung SABR is feasible, efficient and delivers high-precision target dose and lower normal tissue dose.
    Booth J; Caillet V; Briggs A; Hardcastle N; Angelis G; Jayamanne D; Shepherd M; Podreka A; Szymura K; Nguyen DT; Poulsen P; O'Brien R; Harris B; Haddad C; Eade T; Keall P
    Radiother Oncol; 2021 Feb; 155():131-137. PubMed ID: 33152399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric Comparison of Real-Time MRI-Guided Tri-Cobalt-60 Versus Linear Accelerator-Based Stereotactic Body Radiation Therapy Lung Cancer Plans.
    Wojcieszynski AP; Hill PM; Rosenberg SA; Hullett CR; Labby ZE; Paliwal B; Geurts MW; Bayliss RA; Bayouth JE; Harari PM; Bassetti MF; Baschnagel AM
    Technol Cancer Res Treat; 2017 Jun; 16(3):366-372. PubMed ID: 28168936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technical Note: Dosimetric evaluation of Monte Carlo algorithm in iPlan for stereotactic ablative body radiotherapy (SABR) for lung cancer patients using RTOG 0813 parameters.
    Pokhrel D; Badkul R; Jiang H; Kumar P; Wang F
    J Appl Clin Med Phys; 2015 Jan; 16(1):5058. PubMed ID: 25679161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR-guided Gated Stereotactic Radiation Therapy Delivery for Lung, Adrenal, and Pancreatic Tumors: A Geometric Analysis.
    van Sörnsen de Koste JR; Palacios MA; Bruynzeel AME; Slotman BJ; Senan S; Lagerwaard FJ
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):858-866. PubMed ID: 30061007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk Locations.
    Regnery S; Buchele C; Weykamp F; Pohl M; Hoegen P; Eichkorn T; Held T; Ristau J; Rippke C; König L; Thomas M; Winter H; Adeberg S; Debus J; Klüter S; Hörner-Rieber J
    Front Oncol; 2021; 11():757031. PubMed ID: 35087746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a simplified optimizer for MR-guided adaptive RT in case of pancreatic cancer.
    Cusumano D; Boldrini L; Menna S; Teodoli S; Placidi E; Chiloiro G; Placidi L; Greco F; Stimato G; Cellini F; Valentini V; Azario L; De Spirito M
    J Appl Clin Med Phys; 2019 Sep; 20(9):20-30. PubMed ID: 31444952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.